Tissue study for people getting CAR-T cell therapy
Part of Cancer, Immune system & allergy clinical trials.
This study looks at tissue samples from adults who are receiving CAR-T cell therapy for blood-related conditions. It aims to learn more about how CAR-T works and what changes happen in the body, which may help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a blood-related (hematologic) condition and be scheduled for CAR-T therapy at the Bologna Advanced Cell Therapy Program
- Be able to sign an informed consent form and agree to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a patient’s genetic (molecular) information while they receive CAR-T cell therapy. The goal is to better understand how different biological factors may affect CAR-T treatment.
This study tracks infections in people who receive CAR-T cell therapy for certain blood cancers like multiple myeloma and B-cell non-Hodgkin lymphoma. It aims to understand how often infections happen and how to prevent them.
This study looks at the rehabilitation needs of people with blood cancers who are about to have a stem cell transplant or CAR T-cell therapy. It aims to understand what kind of support patients need to stay active and recover better.
This study is for people with blood cancers who are treated with CAR-T cell therapy. Researchers will follow participants over time to learn more about how this therapy works in the real world.
This study looks at immune system “fingerprints” in people who are planning to receive CAR-T cells. It may help doctors understand how the immune system responds to CAR-T and improve future care.
This study collects blood and tissue samples from adults receiving CAR-T cell therapy (an advanced cancer treatment) to understand why it works well for some patients but not others. The goal is to find biological markers that predict treatment success.
Hear when a new CAR-T Therapy Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.